The effects of selective and nonselective phosphodiesterase inhibitors on phagocytic cells in mice

Immunopharmacology and Immunotoxicology

Volumn 32, Issue 3, 2010, Pages 507-513

  Szczypka, Marianna ^a   Obmiska Mrukowicz, Boena ^a  

^a WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

IL 1 ; nitric oxide; Oxidative burst; PDE inhibitors; Phagocytosis

Indexed keywords

AMINOPHYLLINE; AMINOPHYLLINUM; INTERLEUKIN 1BETA; MILRINONE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSAGE SCHEDULE COMPARISON; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; GRANULOCYTE; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PRIORITY JOURNAL; RESPIRATORY BURST;

AMINOPHYLLINE; ANIMALS; FEMALE; INTERLEUKIN-1BETA; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MILRINONE; MONOCYTES; NITRIC OXIDE; PHAGOCYTES; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; RESPIRATORY BURST; SULFONES;

MUS;

EID: 77955474296     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903359850     Document Type: Article

References (27)

1. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58(3):488-520.
2. Burnouf C, Pruniaux MP. Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr Pharm Des 2002; 8(14):1255-1296.
3. Torphy TJ. Phosphodiesterase isozymes. Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 1998; 157(2):351-370.
4. Dal Piaz V., Giovannoni MP. Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies. Eur J Med Chem 2000; 35(5):463-480.
5. Dyke HJ. Montana, JG. Update on the therapeutic potential of PDE4 inhibitors. Expert Opin Investig Drugs 2002; 11(1):1-13.
6. Banner KH, Page CP. Immunomodulatory actions of xanthines and isoenzyme selective phosphodiesterase inhibitors. Monaldi Arch Chest Dis 1995; 50(4):286-292.
7. Beshay E, Croze F, Prudhomme GJ. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol 2001; 98(2):272-279.
8. Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G. Cyclic nucleotide phosphodiesterase type IV Participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol 1995; 155(10):4909-4916.
9. Rieneck K, Diamant M, Haahr P-M, Schonharting M, Bendtzen K. In vitro immunomodulatory effects of pentoxifylline. Immunol Lett 1993; 37(2-3):131-138.
10. Spina D, Landells LJ, Page CP. The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as anti-inflammatory drugs. Clin Exp Allergy 1998; 28(Suppl 3):24-34.
11. Zabel P, Schade FU, Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993; 187(3-5):447-463.
12. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, et al. The effect of phosphodiesterase III inhibitors on human neutrophil function. Crit Care Med 2000; 28(4):1001-1005.
13. Molnar-Kimber K, Yonno L, Heaslip R, Weichman B. Modulation of TNF-α and IL-β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Actions 1993; 39 Spec No:C77-C79.
14. Nielson CP, Vestal RE, Sturm RJ, Heaslip R. Effects of selective Phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol 1990; 86(5):801-808.
15. Toward TJ, Smith N, Broadley KJ. Effect of phosphodiesterase-5 inhibitor, sildenafil (viagra), in animal models of airways disease. Am J Respir Crit Care Med 2004; 169(2):227-234.
16. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82(22):7738-7742.
17. Tenor H, Hatzelmann A, Kupferschmidt R, Stanciu L, Djukanowic R, Schudt C, et al. Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages. Clin Exp Allergy 1995; 25(7):625-633.
18. Gantner F, Kupferschmidt R, Schudt C, Wendel A, Hatzelmann A. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Br J Pharmacol 1997; 121(2):221-231.
19. Nemeth ZH, Szabo C, Hasko G, Salzman AL, Vizi ES. Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages. Eur J Pharmacol 1997; 339(2-3):215-231.
20. Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, et al. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMPphosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 1995; 272(3):1313-1320.
21. Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Watanabe S, et al. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Gen Pharmacol 1997; 29(4):633-638. (Pubitemid 27421432)
22. Haddad JJ, Land SC, Tarnow-Mordi WO, Zembala M, Kowalczyk D, Lauterbach R. Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells. J Pharmacol Exp Ther 2002; 300(2):559-566.
23. Masaki Y, Sato W, Kayaba M, Enzan K, Suzuki M. Milrinone suppresses TNF-alpha and IL-1 beta release in mouse peritoneal macrophages. [in Japanese]. Masui 1995; 44(6):800-804.
24. Nemeth ZH, Hasko G, Szabo C, Vizi ES. Amrinone and teophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock 1997; 7(5):371-375.
25. Greten TF, Eigler A, Sinha B, Moeller J, Enders S. The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxide. Int J Immunopharmacol 1995; 17(7):605-610.
26. Kim KO, Park SY, Han CW, Chung HK, Yoo DH, Han JS. Effect of sildenafil citrate on interleukin-1beta-induced nitric oxide synthesis and iNOS expression in SW982 cells. Exp Mol Med 2008; 40(3):286-293.
27. Wright CD, Kuipers PJ, Kobylarz-Singer D, Devall LJ, Klinkefus BA, Weishaar RE. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMPinsensitive phosphodiesterase. Biochem Pharmacol 1990; 40(4):699-707.